Clean insights and information easily found, page-134

So what’s going on?
we now know Telix didn’t make it to the NASDAQ
Old school wanted Per to go on the Nasdaq without any runs on the board..( not easy )
We see Sarepta in a free fall
could go from $125 to $112 in the next few days
Does it effect PER
NO
I’m glad the FDA is getting tough.. no efficacy and not
achieving end points is a no go !
Per is going slow and steady..

Getting the “right people “ for a Big job.
We will know about partners in a few months.. takes time once again to get the “right fit .”
All in all I’m happy with the progress
We wait